Xiaolan Ruan

522 total citations
27 papers, 352 citations indexed

About

Xiaolan Ruan is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaolan Ruan has authored 27 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaolan Ruan's work include Head and Neck Cancer Studies (6 papers), Lung Cancer Research Studies (5 papers) and Cancer-related molecular mechanisms research (4 papers). Xiaolan Ruan is often cited by papers focused on Head and Neck Cancer Studies (6 papers), Lung Cancer Research Studies (5 papers) and Cancer-related molecular mechanisms research (4 papers). Xiaolan Ruan collaborates with scholars based in China, Germany and United States. Xiaolan Ruan's co-authors include Sheng Li, Xian‐Tao Zeng, Xinghuan Wang, Weidong Hu, Donghu Yu, Tong-Zu Liu, Hong Weng, Chen Chen, Chao Zhang and Zhe Meng and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Xiaolan Ruan

26 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolan Ruan China 13 133 107 75 65 64 27 352
Andrew Ju United States 9 219 1.6× 52 0.5× 10 0.1× 82 1.3× 38 0.6× 37 406
Hubert G. Bartels United States 13 98 0.7× 99 0.9× 10 0.1× 105 1.6× 51 0.8× 52 459
Jian Zhu China 10 145 1.1× 76 0.7× 7 0.1× 90 1.4× 42 0.7× 32 401
Mazen Sudah Finland 16 159 1.2× 74 0.7× 20 0.3× 120 1.8× 228 3.6× 40 714
Xavier Farré Spain 10 78 0.6× 109 1.0× 7 0.1× 78 1.2× 57 0.9× 28 334
Giovanni Capitanio Italy 12 132 1.0× 58 0.5× 14 0.2× 134 2.1× 166 2.6× 21 452
Gareth Bryson United Kingdom 9 57 0.4× 70 0.7× 5 0.1× 61 0.9× 36 0.6× 20 274
C. Chira France 9 194 1.5× 27 0.3× 10 0.1× 130 2.0× 37 0.6× 34 333
Fatma Tokat Türkiye 12 92 0.7× 59 0.6× 26 0.3× 67 1.0× 23 0.4× 45 378
Timothy P. Mate United States 11 434 3.3× 37 0.3× 20 0.3× 88 1.4× 192 3.0× 30 801

Countries citing papers authored by Xiaolan Ruan

Since Specialization
Citations

This map shows the geographic impact of Xiaolan Ruan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolan Ruan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolan Ruan more than expected).

Fields of papers citing papers by Xiaolan Ruan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolan Ruan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolan Ruan. The network helps show where Xiaolan Ruan may publish in the future.

Co-authorship network of co-authors of Xiaolan Ruan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolan Ruan. A scholar is included among the top collaborators of Xiaolan Ruan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolan Ruan. Xiaolan Ruan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, X., Lin Deng, Yufei Pan, et al.. (2024). Case report: Toripalimab plus anlotinib in postoperative recurrent renal pelvic sarcomatoid urothelial carcinoma. Frontiers in Oncology. 14. 1397855–1397855.
2.
Zhang, Bin, Jiän Zhang, Rongjun Zhang, et al.. (2024). Intensity-modulated radiotherapy alone compared with intensity-modulated radiotherapy plus concurrent chemotherapy in intermediate-risk nasopharyngeal carcinoma. Strahlentherapie und Onkologie. 200(10). 867–875. 1 indexed citations
3.
4.
Zhang, Bin, Rui Cai, Xiangyun Kong, et al.. (2024). Induction Chemotherapy Followed by Radiotherapy vs Chemoradiotherapy in Nasopharyngeal Carcinoma. JAMA Oncology. 10(4). 456–456. 13 indexed citations
5.
Shen, Hui, Liye Mei, Li Liu, et al.. (2023). Typing of acute leukemia by intelligent optical time-stretch imaging flow cytometry on a chip. Lab on a Chip. 23(6). 1703–1712. 12 indexed citations
6.
Kong, Yue, Yugeng Liu, Xianzhe Li, et al.. (2023). Palmitoylation landscapes across human cancers reveal a role of palmitoylation in tumorigenesis. Journal of Translational Medicine. 21(1). 826–826. 16 indexed citations
7.
Ruan, Xiaolan, et al.. (2022). Identification and Analysis of Senescence-Related Genes in Head and Neck Squamous Cell Carcinoma by a Comprehensive Bioinformatics Approach. Mediators of Inflammation. 2022. 1–15. 5 indexed citations
8.
Yang, Huiyun, Rongjun Zhang, Bin Zhang, et al.. (2022). Nomogram for distant metastasis-free survival in patients with locoregionally advanced nasopharyngeal carcinoma. Strahlentherapie und Onkologie. 198(9). 828–837. 4 indexed citations
9.
Wang, Biao, Bangshun He, Xiaolan Ruan, et al.. (2022). An integrated microfluidics platform with high-throughput single-cell cloning array and concentration gradient generator for efficient cancer drug effect screening. Military Medical Research. 9(1). 51–51. 22 indexed citations
10.
Yu, Donghu, Chen Chen, Xiaoping Liu, et al.. (2021). Dysregulation of miR-138-5p/RPS6KA1-AP2M1 Is Associated With Poor Prognosis in AML. Frontiers in Cell and Developmental Biology. 9. 641629–641629. 17 indexed citations
11.
12.
Ruan, Xiaolan, Xiaoping Liu, Haoli Ma, et al.. (2020). Analysis of the Interaction Network of Hub miRNAs-Hub Genes, Being Involved in Idiopathic Pulmonary Fibers and Its Emerging Role in Non-small Cell Lung Cancer. Frontiers in Genetics. 11. 302–302. 34 indexed citations
13.
Zhang, Rongjun, Bin Zhang, Yuan Xie, et al.. (2020). Feasibility and efficiency of double-agent versus single-agent concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma. Oral Oncology. 106. 104704–104704. 1 indexed citations
14.
Yu, Donghu, Wei Li, Xiaoping Liu, et al.. (2020). Screening and Functional Analysis of Hub MicroRNAs Related to Tumor Development in Colon Cancer. BioMed Research International. 2020(1). 3981931–3981931. 5 indexed citations
15.
Yu, Donghu, Jingyu Huang, Xiaoping Liu, et al.. (2019). Effects of hub genes on the clinicopathological and prognostic features of lung adenocarcinoma. Oncology Letters. 19(2). 1203–1214. 17 indexed citations
16.
Li, Sheng, Joey S.W. Kwong, Xian‐Tao Zeng, et al.. (2015). Plasmakinetic resection technology for the treatment of benign prostatic hyperplasia: evidence from a systematic review and meta-analysis. Scientific Reports. 5(1). 12002–12002. 14 indexed citations
17.
Ruan, Xiaolan, et al.. (2015). The Role of TP53 Gene Codon 72 Polymorphism in Leukemia. Medicine. 94(38). e1588–e1588. 5 indexed citations
18.
19.
Ruan, Xiaolan, Sheng Li, Xian‐Tao Zeng, Linghui Xia, & Yu‐Feng Hu. (2013). No association between cytochrome P450 2D6 gene polymorphism and risk of acute leukemia: evidence based on a meta-analysis. Chinese Medical Journal. 126(19). 3750–3753. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew Ju Breakdown of academic impact, for papers by Hubert G. Bartels Breakdown of academic impact, for papers by Jian Zhu Breakdown of academic impact, for papers by Mazen Sudah Breakdown of academic impact, for papers by Xavier Farré Breakdown of academic impact, for papers by Giovanni Capitanio Breakdown of academic impact, for papers by Gareth Bryson Breakdown of academic impact, for papers by C. Chira Breakdown of academic impact, for papers by Fatma Tokat Breakdown of academic impact, for papers by Timothy P. Mate
Rankless by CCL
2026